Synopsis A recent study demonstrated that circulating B-type natriuretic peptide (BNP) level is a stronger predictor of mortality for patients without heart failure (HF) than traditional risk factors. This week's ' MED FACT ' discusses a study from the ‘Journal of the American College of Cardiology’, " B-Type Natriuretic Peptide Levels and Mortality in Patients With and Without Heart Failure ”. Authors : Michelle K. York et al.
Key Takeaways: Plasma BNP level is a stronger predictor of mortality among patients without HF. Objective Study Type Participants To Compare The Prognostic Value Of BNP Between Patients With And Those Without HF Retrospective Study 30,487 Patients What Was The Need For This Study? B-type natriuretic peptide (BNP) is secreted into the circulation in response to increased cardiac wall stress. Thus, it is a clinically robust diagnostic biomarker for…
